Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.52EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.52ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.52ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.52EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.52EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XMEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XMECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XMECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XMEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XMEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.70EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.70ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.70ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.70EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.70EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.63EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.63ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.63ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.63EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.63EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.8.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.8.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used